Cancer Research UK
- Country
- ๐ฌ๐งUnited Kingdom
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- 1K
- Market Cap
- -
Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2011-07-11
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 34
- Registration Number
- NCT01390571
- Locations
- ๐ฌ๐ง
Bristol Haematology and Oncology Centre, Bristol, England, United Kingdom
๐ฌ๐งAddenbrooke's Hospital, Cambridge, England, United Kingdom
๐ฌ๐งChristie Hospital, Manchester, England, United Kingdom
NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2011-03-28
- Last Posted Date
- 2015-03-05
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 6
- Registration Number
- NCT01324115
- Locations
- ๐ฌ๐ง
Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood, England, United Kingdom
Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2010-11-03
- Last Posted Date
- 2013-10-08
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 36
- Registration Number
- NCT01233492
- Locations
- ๐ฌ๐ง
Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham, England, United Kingdom
๐ฌ๐งCancer Research UK Clinical Trials Unit - Birmingham, Birmingham, England, United Kingdom
Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2010-10-18
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 45
- Registration Number
- NCT01222221
- Locations
- ๐ฌ๐ง
Addenbrooke's Hospital, Cambridge, England, United Kingdom
๐ฌ๐งUCL Cancer Institute, London, England, United Kingdom
๐ฌ๐งSouthampton General Hospital, Southampton, England, United Kingdom
Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer
- Conditions
- Breast CancerColorectal CancerGastric CancerLung CancerOvarian CancerPancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2010-10-01
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 14
- Registration Number
- NCT01212887
- Locations
- ๐ฌ๐ง
Christie Hospital, Manchester, England, United Kingdom
Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer
- Conditions
- Gastric CancerHead and Neck CancerLymphomaLymphoproliferative DisorderNonneoplastic Condition
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 16
- Registration Number
- NCT01147991
- Locations
- ๐ฌ๐ง
University of Birmingham, Birmingham, England, United Kingdom
๐ฌ๐งRoyal Marsden - London, London, England, United Kingdom
๐ฌ๐งChristie Hospital, Manchester, England, United Kingdom
GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2012-05-01
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 35
- Registration Number
- NCT01147029
- Locations
- ๐ฌ๐ง
Christie Hospital, Manchester, England, United Kingdom
๐ฌ๐งChurchill Hospital, Oxford, England, United Kingdom
Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2010-05-28
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Cancer Research UK
- Registration Number
- NCT01132599
- Locations
- ๐ฌ๐ง
St. Thomas' Hospital, London, England, United Kingdom
Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2010-05-06
- Last Posted Date
- 2013-05-01
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 38
- Registration Number
- NCT01118611
- Locations
- ๐ฌ๐ง
Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
๐ฌ๐งBarts and the London School of Medicine, London, England, United Kingdom
MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2010-04-02
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 44
- Registration Number
- NCT01098344
- Locations
- ๐ฌ๐ง
Addenbrooke's Hospital, Cambridge, England, United Kingdom
๐ฌ๐งLeicester Royal Infirmary, Leicester, England, United Kingdom
๐ฌ๐งBarts and the London School of Medicine, London, England, United Kingdom